Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: AC Immune, Aim, Allecra, Amicus, Arch, Arrowhead, Astrazeneca, Benitec, Briacell, Bristol Myers Squibb, Dermata, Eton, Forcast, Genprex, GSK, Horizon, Immix, Moberg, Napo, Nervgen, Paratek, Pfizer, Opko, Reata, Regeneron, Specialised, Theriva, UCB, Verona, Xuanzhu.